Intuitive Surgical, Inc. $ISRG Shares Sold by William Blair Investment Management LLC

Key Points

• William Blair Investment Management LLC significantly reduced its stake in Intuitive Surgical by 58.6%, owning 35,775 shares valued at approximately $19.4 million after selling over 50,000 shares.
• Analysts have mixed views on Intuitive Surgical, with predictions of a price target ranging from $567 to $599, while the average rating remains a "Moderate Buy" with a target price of $580.29.
• Shares of Intuitive Surgical have been fluctuating around $446.13, with a reported 21.4% year-over-year revenue increase last quarter, exceeding analyst estimates for both revenue and earnings per share.

William Blair Investment Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 58.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,775 shares of the medical equipment provider's stock after selling 50,620 shares during the quarter. William Blair Investment Management LLC's holdings in Intuitive Surgical were worth $19,440,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Chilton Capital Management LLC boosted its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ISRG has been the subject of several analyst reports. Wells Fargo & Company upped their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating for the company in a research report on Wednesday, October 1st. Wall Street Zen downgraded Intuitive Surgical from a "buy" rating to a "hold" rating in a report on Saturday. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $580.29.

Intuitive Surgical Stock Up 2.6%

ISRG opened at $446.13 on Monday. The business has a 50 day moving average price of $454.97 and a two-hundred day moving average price of $495.76. The company has a market cap of $159.93 billion, a PE ratio of 62.22, a P/E/G ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.78 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last ninety days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.